Trademark: 79305894
Word
BELMONITOR COV-2
Status Date
Tuesday, May 24, 2022
Registration Number
6720755
Registration Date
Tuesday, May 24, 2022
Filing Date
Tuesday, December 22, 2020
Published for Opposition
Tuesday, February 22, 2022
5 Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2
10 Genetic testing apparatus for medical purposes for diagnosing exposure to Sars-Cov-2; chromatogram analyzers for medical use; patient monitoring sensors and alarms; chromatographic instruments for medical use; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; chromatographic apparatus for medical use; physical analyzers for medical use, namely, hematology analyzers for medical diagnostic uses, body composition analyzers for medical purposes, skin moisture analyzers for medical purposes, analyzers for the analysis of body fluids; medical diagnostic saliva pads; immunoadsorption columns for medical diagnostic use; chromatographic columns for medical use; apparatus for blood monitoring for medical use; spittoons for medical purposes; all of the foregoing for use in diagnosing or treating Sars-Cov-2 infections
The mark consists of the wording "BelMonitor" in stylized letter with "BEL" in dark blue and "MONITOR" in light blue with "COV-2" in white letters inside a light blue rectangle beneath the letters "BEL".
BELMONITOR COV-TWO
The color(s) light blue, dark blue and white is/are claimed as a feature of the mark.
"COV-2"
Sep 14, 2022
Generic Madrid Transaction Sent To Ib
Sep 14, 2022
Generic Madrid Transaction Created
Aug 24, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Feb 22, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 22, 2022
Published For Opposition
Feb 20, 2022
Notification Processed By Ib
Feb 2, 2022
Notification Of Possible Opposition Sent To Ib
Feb 2, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 2, 2022
Notification Of Notice Of Publication E-Mailed
Jan 14, 2022
Approved For Pub - Principal Register
Jan 11, 2022
Teas/Email Correspondence Entered
Jan 10, 2022
Correspondence Received In Law Office
Jan 10, 2022
Teas Response To Office Action Received
Aug 1, 2021
Refusal Processed By Ib
Jul 14, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jul 14, 2021
Refusal Processed By Mpu
Jul 13, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jul 12, 2021
Non-Final Action Written
Jul 7, 2021
Assigned To Examiner
Jun 28, 2021
Assigned To Examiner
Jun 18, 2021
Assigned To Examiner
Mar 12, 2021
Application Filing Receipt Mailed
Mar 8, 2021
New Application Office Supplied Data Entered In Tram
Mar 4, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24